Want to join the conversation?
During 4Q15, $C's cost of credit was $2.5Bil, a 25% increase, with a net loan loss reserve build of $588MM, primarily in Institutional Clients Group (ICG), compared to a net loan loss reserve release of $441MM in the prior year period, and partially offset by a 22% decrease in net credit losses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?